Company Overview - FMC reported a total revenue of $3.61 billion and a net income of -$531.8 million for the trailing twelve months (TTM) [5] - The company's dividend yield stands at 11.4%, with the share price as of January 22 being $16.02 [5] Recent Transaction - On January 22, tru Independence sold all 152,855 shares of FMC, resulting in a complete exit from the position, with a decrease in position value of $5.14 million [2][3][7] - FMC previously represented 1.3% of tru Independence's assets under management (AUM) [4][7] Performance Analysis - FMC's share price has decreased by 69.0% over the past year, significantly underperforming the S&P 500, which gained approximately 14% in the same period [4] - The company's third-quarter results showed a 49% year-over-year revenue decline, primarily due to the India business being held for sale, while adjusted EBITDA increased by 17% to $236 million due to cost controls [11] Strategic Focus - FMC is focusing on cost management by exiting high-cost manufacturing and resizing operations in Asia following the divestiture of its India business [12] - The company aims to prioritize balance sheet repair over income, as indicated by a dividend cut to $0.08 per share and a free cash flow outlook that is expected to hover around breakeven [12] Market Position - FMC specializes in crop protection chemicals and agricultural inputs, serving commercial farmers and agricultural businesses globally [9][10] - The company combines a diverse product portfolio with a broad geographic reach, focusing on research-driven innovation and strategic distribution to enhance crop yields and promote sustainable farming practices [10]

Group 1 - FMC Corporation is recognized as one of the 10 Most Promising Green Stocks according to Wall Street Analysts, supported by strong hedge fund backing and favorable analyst ratings [1] - At the Jefferies Mining and Industrials Conference 2025, FMC emphasized its focus on innovation, particularly in expanding its biological portfolio and introducing new active components Fluentapir and Isoflex to address the expiration of its Rynaxypyr patent [2] - FMC reported improved inventory control and described current market conditions as "normalized," reiterating its Q3 and Q4 forecasts, with September sales and the Latin American season identified as key growth drivers [3] Group 2 - In Q2 2025, FMC posted sales of $1.05 billion, exceeding expectations by 5%, and an EPS of $0.69, up from $0.62, while highlighting advancements in Brazil related to cost efficiency and new product introductions [4] - FMC Corporation operates in the agricultural sciences sector, providing crop protection products such as insecticides, herbicides, and fungicides to farmers across various regions including Latin America, North America, Europe, the Middle East, Africa, and Asia [5]